BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11

• 

  Job Trends

  The wait continues: pressure to operate lean among factors behind slow job market

  Just 23% of respondents to a BioSpace LinkedIn poll expect the biopharma job market will rebound in 2026. Three experts discuss when they see a turnaround happening and how increasing emphasis on cost efficiency is impacting hiring practices.

  June 11, 2026

   · 

  4 min read

   · 

  Angela Gabriel
• 

  Job Trends

  May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech

  For the second time in 2026, the number of biopharma professionals affected by made or projected workforce reductions rose year over year. In May, layoffs spiked nearly 50%, mainly due to Takeda and BioNTech axing a combined 6,360 employees.

  June 11, 2026

   · 

  3 min read

   · 

  Angela Gabriel
• 

  Insights

  Portugal, Spain and the new biotech frontier

  In this episode of Denatured, you’ll be hearing from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc as they discuss the rise of Southern Europe’s biotech ecosystem.

  June 11, 2026

   · 

  1 min read

   · 

  Jennifer C. Smith-Parker
• 

  Deals

  Novartis tightens bond with Orionis in up to $1.4B molecular glue deal

  It’s the latest Big Pharma deal for molecular glue technology and Novartis’ second with Orionis Biosciences, after first linking up in March 2020. The backloaded agreement will see Novartis pay $40 million upfront.

  June 11, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Funding

  SonoThera bags $125M series B to advance safer gene therapies

  Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.

  June 11, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IPO tracker

  Kardigan stitches up $369M IPO plan

  Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.

  June 11, 2026

   · 

  16 min read

   · 

  Editorial Team
• 

  Immunology and inflammation

  Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial

  Takeda eyes an FDA run for its investigational psoriasis pill after the drug elicited total skin clearance in more than 35% of patients at 16 weeks—more than 2.5 times that in controls taking Bristol Myers Squibb’s Sotyktu.

  June 11, 2026

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  Applied Biologics Presents Interim CAMPX Clinical Trial Data at the Symposium on Advanced Wound Care (SAWC) Spring 2026

  June 11, 2026

   · 

  4 min read
• Press Releases

  Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB

  June 11, 2026

   · 

  3 min read
• Press Releases

  Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy

  June 11, 2026

   · 

  5 min read